Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer

Published:2015-02 Issue:6 Volume:94 Page:e515
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhang Yaxiong,Kang Shiyang,Shen Jianfei,He Jiaxi,Jiang Long,Wang Wei,Guo Zhihua,Peng Guilin,Chen Gang,He Jianxing,Liang Wenhua

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference34 articles.

1. Checkpoint blockade in cancer immunotherapy.;Korman;Adv Immunol,2006

2. Targeting the PD-1B7-H1(PD-L1) pathway to activate anti-tumor immunity.;Topalian;Curr Opin Immunol,2012

3. Clinical evaluation of compounds targeting PD-1PD-L1 pathway for cancer immunotherapy.;Lu;J Oncol Pharm Pract,2014

4. Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.;Hamid;Expert Opin Biol Ther,2013

5. Inhibitory B7-family molecules in the tumour microenvironment.;Zou;Nat Rev Immunol,2008

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on the prognostic value and clinicopathological significance of different immune checkpoints in patients with colorectal cancer: a systematic review and meta-analysis;Current Therapeutic Research;2024-09

2. Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs;Dermatology Practical & Conceptual;2024-07-31

3. Comparison of programmed death‐ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer;Cancer Reports;2024-04

4. BPIFB1, Serving as a Downstream Effector of EBV-miR-BART4, Blocks Immune Escape of Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression;Biochemical Genetics;2024-03-11

5. Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti−PD-L1 in Cutaneous T-Cell Lymphoma;Journal of Investigative Dermatology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3